Brad W. Hansman was named Executive Vice President, Operations of Medpace Holdings, Inc., effective June 1, 2026. As of November 6, 2026, Medpace Holdings, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 22, 2026 to June 4, 2026, naming 1 appointment and 1 departure (Form 8-K, June 4, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Medpace Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Medpace Holdings, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-22 to 2026-06-04. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Medpace Holdings, Inc. files it.
Also on the record for Medpace Holdings, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 28, 2026 | Stake report, Schedule 13D/A, by August J. Troendle | 19.1% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by T. Rowe Price Associates, Inc. | 7.2% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| December 1, 2025 | Stake report, Schedule 13D/A, by August J. Troendle | 20% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Medpace Holdings, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Medpace Holdings, Inc. and the records around it.
Medpace Holdings, Inc. elsewhere on the record
Companies that share a holder
- T. Rowe Price Associates, Inc. also filed stake reports on 191 other companies: PACIFIC BIOSCIENCES OF CALIF (Nov 2026), APARTMENT INVT & MGMT CO -A (Oct 2026), BETA BIONICS INC (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Medpace Holdings, Inc.
Get an email when Medpace Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Medpace Holdings, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Medpace Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medpace Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-04 | In | Executive Vice President, Operations | 2026-06-01 | 8-K, 2026-06-04 | |
| 2026-04-22 | Out | President | 2026-05-31 | 8-K, 2026-04-22 |
Who leads Medpace Holdings, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Executive Vice President, Operations: Brad W. Hansman, appointed, effective 2026-06-01 (filed 2026-06-04).
- President: Jesse Geiger, departure reported, effective 2026-05-31 (filed 2026-04-22). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Medpace Holdings, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Executive Vice President, Operations at Medpace Holdings, Inc., with the record behind each one.
Find candidates like Operations at Medpace Holdings, Inc.Every change, in the filing's words
Appointed: Brad W. Hansman, Executive Vice President, Operations, effective 2026-06-01
Effective June 1, 2026, Medpace Holdings, Inc. (the " Company ") appointed Brad W. Hansman, age 43, to the position of Executive Vice President, Operations.
- In this role, Mr. Hansman shall perform the functions of the Company's principal operating officer along with Susan E. Burwig, the Company's Executive Vice President, Operations.
- Mr. Hansman joined the Company in April 2011 in Finance & Accounting and held various roles in Finance until July 2015.
- Since August 2015, Mr. Hansman has held various key leadership roles in operations including Executive Director, Vice President, and Senior Vice President overseeing study start-up, logistics, regulatory affairs, and medical writing.
- Prior to joining the Company, Mr. Hansman worked for Joseph Decosimo & Company, LLC as an Audit Supervisor from July 2008 to March 2011.
- Mr. Hansman started his career at Macy's, Inc. where he held various auditor positions from July 2006 to June 2008.
- Mr. Hansman received his Bachelor of Business Administration in Accounting from Eastern Kentucky University and is a Certified Public Accountant (inactive).
- Mr. Hansman does not hold any public company directorships.
Departing: Jesse Geiger, President, effective 2026-05-31
On April 21, 2026, Jesse Geiger notified the Company of his intent to resign as President and that he will retire from the Company effective May 31, 2026.
- This departure is not the result of any disagreement with the Company regarding its operations, policies, or practices.
- Effective on Mr. Geiger's resignation date, the Company's Chief Executive Officer, August Troendle, will reassume the role of President until such time as the Company appoints a successor.
Tools for this story
Each opens in a new tab, filled in for Medpace Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.